Synonym name: Neprotine; Yatrorizine; Jateorhizine; Dehydrocorypalmine
Catalogue No.: BP0808
Cas No.: 3621-38-3
Formula: C₂₀H₂₀NO₄
Mol Weight: 338.383
Botanical Source: Quaternary alkaloid from the root of Jateorhiza palmata, many Berberis and Mahonia spp. Coptis sp., Thalictrum javanicum, Thalictrum cultratum, Tinospora cordifolia, Enantia chloranthra and many other spp. in several families

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle
Can be supplied from milligrams to grams.

For Reference Standard and R&D, Not for Human Use Directly.
Inquire for bulk scale.

Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Natural products, as an important source of drug discovery, play an irreplaceable role in the long history of human struggle against diseases. In the treasure trove of traditional Chinese medicine, Huanglian（Coptis chinensis Franch., as an essential medicine for clearing heat and detoxifying, has a medicinal history dating back over two thousand years. Modern pharmacological research has revealed that the main active ingredient of Huanglian is a class of compounds called isoquinoline alkaloids, among which berberine is the most well-known. However, in the complex chemical composition spectrum of Huanglian, jatrorrhizine, as an equally important berberine type alkaloid, is receiving increasing attention from researchers.

Yaogen alkaloid (CAS number: 3621-38-3) is a naturally occurring quaternary ammonium alkaloid with a chemical structure highly similar to berberine, with only differences in the substituents at C-2 and C-3 positions. This subtle difference in structure endows medicinal alkaloids with a unique and diverse spectrum of biological activities. Early research mainly focused on its antibacterial and anti-inflammatory effects, which are consistent with the traditional efficacy of Huanglian. However, in recent years, with the deepening development of neuroscience and chemical biology, the pharmacological potential of matrine has been continuously explored, especially in the field of central nervous system diseases, showing remarkable prospects.

One of the most notable discoveries of matrine is its role as an acetylcholinesterase (AChE) inhibitor. Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive impairment, and one of its pathological mechanisms is the degeneration of cholinergic neurons and the decrease in acetylcholine (ACh) levels in the brain. Medicinal root alkaloids can effectively inhibit AChE activity (IC50=872 nM), thereby increasing the concentration of ACh in synaptic cleft and improving cholinergic neurotransmission. More importantly, matrine exhibits extremely high selectivity towards butyrylcholinesterase (BuChE) (selectivity index up to 115 times), indicating that it may have lower side effects, as BuChE is present in lower levels in normal brain tissue but significantly increases during AD progression. Selective inhibition of AChE may be more beneficial for maintaining normal cholinergic function. In addition, matrine can also reduce the reuptake of serotonin (5-HT) and norepinephrine (NE) by inhibiting the activity of uptake-2 transporter, providing a theoretical basis for its application in mental disorders such as depression.

In addition to neuroprotective effects, the antibacterial activity of matrine, especially its potential to target drug-resistant strains, is also a current research hotspot. Faced with the increasingly severe crisis of antibiotic resistance, it is particularly urgent to find new antibacterial strategies from natural products. Medicinal root alkaloids exhibit inhibitory effects on various bacteria and fungi, and their targets may involve bacterial DNA gyrase (GyrA/GyrB), cell division protein FtsZ, fatty acid synthase FabI, dihydrofolate reductase DHFR, as well as fungal ergosterol synthesis pathways (such as ERG11/CYP51) and multidrug resistance transporters (such as CDR1). This multi-target mechanism of action makes it difficult for matrine to induce bacterial resistance and may have a synergistic effect with traditional antibiotics.

This review aims to comprehensively and systematically review the research progress of medicinal root alkaloids. We will start from its chemical structure and physicochemical properties, explore its plant origin and extraction process, deeply analyze its diverse pharmacological activities, especially its neuroprotective and antibacterial effects, and elaborate on its molecular mechanism of action. On this basis, the potential of the drug as a lead compound or a candidate drug is evaluated by combining the pharmaceutical properties and pharmacokinetic characteristics. Finally, the clinical application prospects of the drug in neurodegenerative diseases, infectious diseases and mental disorders are prospected. Through in-depth analysis of medicinal alkaloids, we hope to provide valuable references and inspirations for the modern drug development of this ancient natural product.

Chemical structure and physicochemical properties

Jatrorrhizine belongs to the protoberberine class of isoquinoline alkaloids, and its chemical structure is centered around a four ring isoquinoline skeleton, namely 5,6-dihydrodibenz [a, g] quinolone. Its molecular formula is C20H20NO4+and its molecular weight is 338.3830 g/mol. Compared with berberine, the structural difference of berberine is that the C-2 and C-3 positions of berberine are bridged by a methoxy group (- O-CH2-O -), while the C-2 position of berberine is methoxy (- OCH3) and the C-3 position is hydroxyl (- OH). Specifically, the chemical name of jatrorrhizine is 2,3,9,10-tetramethoxy-5,6-dihydroisoquinoline [3,2-a] isoquinoline 7-ium (2,3,9,10-tetramethoxy-5,6-dihydroisoquinoline [3,2-a] isoquinoline 7-ium), but the more common name is 2-hydroxy-3,9,10-trimethoxy-5,6-dihydroisoquinoline [3,2-a] isoquinoline 7-ium (2-hydroxy-3,9,10-trimethoxy-5,6-dihydroisoquinoline [3,2-a] isoquinoline 7-ium), which accurately reflects that its C-2 position is a hydroxyl group, C-3, C-9, C-1-1 is a hydroxyl group. The 0 position is a characteristic of methoxy group.

The molecule of root alkaloids contains a positively charged quaternary ammonium nitrogen atom (N+), making it a strongly polar quaternary ammonium salt. This structural feature profoundly affects its physical and chemical properties. Its lipid water partition coefficient (LogP) is 0.5732, indicating that it has a certain hydrophilicity, but is not completely water-soluble. Its water solubility parameter is 0.4907, which is at a moderate to low level. The topological polar surface area (TPSA) is 51.8000 Å ², which is a relatively high value reflecting the presence of multiple polar groups (hydroxyl, methoxy, and quaternary ammonium ions) in the molecule. High TPSA values are usually associated with poor cell membrane permeability and blood-brain barrier (BBB) penetration ability. In fact, the BBB penetration ability of matrine has been evaluated as "low", which is closely related to its quaternary ammonium salt structure and high polarity. This characteristic is not only a challenge for its development as a central nervous system drug, but also may become an advantage for its peripheral antibacterial and anti-inflammatory effects without easily producing central side effects.

Medicinal root alkaloids can emit strong yellow fluorescence under ultraviolet light, which is a typical feature of berberine compounds. Its UV visible absorption spectrum usually has characteristic absorption peaks around 230 nm, 270 nm, 340 nm, and 430 nm. Under acidic conditions, matrine exists in the form of quaternary ammonium salts, which are stable and relatively water-soluble; Under alkaline conditions, quaternary ammonium ions may undergo ring opening reactions, forming aldehyde or alcohol structures, leading to a decrease in their stability. Therefore, during the extraction, separation, and storage processes, it is usually necessary to maintain an appropriate acidic environment.

Plant sources and extraction methods

Medicinal root alkaloids were originally derived from the medicinal roots of plants in the family Menispermaceae（Jateorhiza palmata Also known as African self-defense, it was separated and named, which is the origin of its name "Jatrorrhizine". However, subsequent studies have found that jatrorrhizine is widely distributed in nature, especially in the Ranunculaceae family and the Huanglian genus（Coptis）Plants are rich in content. Except for Huanglian（C. chinensis）Sanjiaoye Huanglian（C. deltoidea）Yunnan Huanglian（C. teeta）Waiting is also an important source of medicinal alkaloids. In addition, there are various plants in the Menispermaceae family, such as the yellow vine（Fibraurea recisa）Tian Xian Teng（Fibraurea tinctoria）Medicinal alkaloids can also be detected in certain plants of the Berberidaceae family. There are significant differences in the content of alkaloids in medicinal herbs from different plant sources, origins, and harvest periods. In Huanglian, jatrorrhizine is usually one of the main alkaloids with a content second only to berberine and palmatine, and its content generally ranges from 0.5% to 2%.

The extraction method of root alkaloids is mainly based on the polarity characteristics of their quaternary ammonium salts. Traditional extraction methods often use solvent extraction, taking advantage of the high solubility of alkaloids in acidic alcohols or water. Common extraction solvents include methanol, ethanol, water, or their mixed solutions, and small amounts of hydrochloric acid or sulfuric acid are often added to maintain an acidic environment and promote the dissolution of alkaloids. The extraction process usually includes reflux extraction, percolation extraction, or ultrasound assisted extraction. For example, Huanglian powder can be refluxed and extracted 2-3 times with 70% ethanol (containing 0.5% hydrochloric acid) at 60-70 ℃, and the extracted solutions can be combined and concentrated under reduced pressure to obtain an extract rich in total alkaloids.

In order to isolate and purify alkaloids from total alkaloids, it is necessary to utilize their subtle differences in structure and polarity with other alkaloids such as berberine and palmatine. Common separation methods include:
1. Column chromatography method This is the most commonly used method. Typically, silica gel column chromatography is used with gradient elution using solvent systems such as chloroform methanol water or ethyl acetate methanol water. Due to the polarity of jatrorrhizine being between berberine and palmatine, effective separation can be achieved by optimizing the elution conditions. In addition, alumina column chromatography, polyamide column chromatography and Sephadex LH-20 column chromatography are also often used for further purification.
2. High performance liquid chromatography (HPLC)Preparation HPLC is an effective method for obtaining high-purity root alkaloids (>98%). Usually, a reverse phase C18 chromatographic column is used, with acetonitrile water (containing phosphate buffer or formic acid) as the mobile phase, and separation is carried out under the monitoring of a UV detector (usually 270 nm or 345 nm).
3. High Speed Counter Current Chromatography (HSCCC)This is a chromatographic technique based on the liquid-liquid distribution principle, which avoids irreversible adsorption of samples on solid stationary phases and has the advantages of high recovery rate and large sample loading capacity. Choosing a suitable solvent system (such as n-butanol acetic acid water) can efficiently separate alkaloids from the total alkaloids of Coptis chinensis.
4. Precipitation method Separation is achieved by utilizing the differences in solubility of different alkaloids in specific solvents. For example, the hydrochloride or sulfate salt of berberine has low solubility in water and is prone to precipitation, while the corresponding salt of berberine has relatively high solubility and can be retained in the mother liquor to achieve preliminary separation.

In recent years, some green and efficient extraction technologies have also been applied to the extraction of medicinal alkaloids, such as microwave-assisted extraction, enzyme assisted extraction, and supercritical fluid extraction. These methods aim to improve extraction efficiency, shorten extraction time, and reduce the use of organic solvents. However, due to limitations in cost and technological maturity, traditional solvent extraction combined with column chromatography separation is still the main way to obtain alkaloids in laboratory research and industrial production.

Pharmacological activity research

Jatrorrhizine shows extensive and significant pharmacological activities, covering the nervous system, infectious diseases, metabolic disorders and inflammation and other fields. Among them, neuroprotection and antibacterial activity are the two most in-depth research directions.

1. Neuroprotection and anti Alzheimer's disease activity

The neuroprotective effects of matrine are one of its most promising research areas. The core mechanism lies in its inhibitory effect on cholinesterase. As mentioned earlier, matrine is an effective inhibitor of acetylcholinesterase (AChE) (IC50=872 nM) and exhibits extremely high selectivity towards butyrylcholinesterase (BuChE) (selectivity index 115 times). This selectivity is crucial because BuChE is mainly present in glial cells in healthy brain tissue, while AChE is mainly present in neurons. In the late stage of AD, AChE activity decreases while BuChE activity compensatorily increases, jointly participating in the deposition of A β plaques. Therefore, selective inhibition of AChE may be more effective in improving early cognitive symptoms of AD, while reducing peripheral side effects that may arise from BuChE inhibition.

In addition to inhibiting AChE, the neuroprotective effects of matrine are also reflected in the following aspects:
- anti-oxidative stress Medicinal root alkaloids can directly scavenge free radicals, such as hydroxyl radicals and superoxide anions, and enhance the activity of endogenous antioxidant enzymes (such as superoxide dismutase (SOD) and catalase (CAT)) in cells, thereby reducing oxidative stress damage to neurons.
- Anti beta amyloid (A β) toxicity The aggregation and deposition of A β are the core pathological features of AD. Research has shown that matrine can inhibit the aggregation of A β and reduce A β - induced neuronal apoptosis. The mechanism may be related to regulating mitochondrial function and inhibiting caspase-3 activation.
- Anti neuroinflammation Overactivation of microglia is an important source of neuroinflammation in AD. Yaogen alkaloid can inhibit the activation of microglia induced by lipopolysaccharide (LPS) or A β, reduce the release of pro-inflammatory factors (such as TNF - α, IL-1 β, IL-6) and nitric oxide (NO), thereby exerting anti-inflammatory and neuroprotective effects.
- Regulating monoamine neurotransmitters Yaogen alkaloids increase the concentration of these monoamine neurotransmitters in synaptic cleft by inhibiting the uptake-2 transporter, reducing the reuptake of serotonin (5-HT) and norepinephrine (NE). This mechanism is not only related to antidepressant effects, but may also indirectly improve cognitive and emotional disorders in AD patients by regulating neurotransmitter balance.

2. Antibacterial activity

Medicinal root alkaloids have broad-spectrum antibacterial activity against various pathogenic microorganisms, including Gram positive bacteria, Gram negative bacteria, and fungi. Its antibacterial mechanism is complex, involving multiple targets, which is also its advantage of not easily developing drug resistance.
- antibacterial Medicinal root alkaloids have inhibitory effects on Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus MRSA), Escherichia coli, Helicobacter pylori, Mycobacterium tuberculosis, and other bacteria. Its targets include:
- DNA gyrase (GyrA/GyrB)Inhibit bacterial DNA replication.
- Cell division protein FtsZ Interference with bacterial cell division.
- Vinyl ACP Reductase (FabI)Inhibit bacterial fatty acid synthesis.
- Dihydrofolate reductase (DHFR)Interference with bacterial folate metabolism.
- antifungal Medicinal root alkaloids also exhibit inhibitory effects on common pathogenic fungi such as Candida albicans and Cryptococcus neoformans. Its mechanism of action is related to the targeted fungal cell membrane ergosterol synthesis pathway, especially the inhibition of 14 α - demethylase (ERG11/CYP51), which leads to the obstruction of ergosterol synthesis and damage to cell membrane integrity. In addition, matrine can also inhibit the multidrug resistance transporter proteins (such as CDR1) of fungi, thereby reversing their resistance to azole drugs.

3. Other pharmacological activities

• Anti malaria parasite Yaogen alkaloid has a killing effect on malignant malaria parasites, and its mechanism may be related to inhibiting the DNA synthesis of malaria parasites or interfering with their heme detoxification process.
• Anti inflammatory and immune regulation In addition to its role in neuroinflammation, matrine also exhibits anti-inflammatory activity in systemic inflammation models, which can inhibit the production of various inflammatory mediators.
• Cardiovascular protection Some studies have shown that matrine has vasodilatory, antiplatelet aggregation, and anti myocardial ischemia-reperfusion injury effects.
• antitumor Jatrorrhizine has cytotoxicity to many cancer cell lines (such as liver cancer, lung cancer, breast cancer cells) and can induce cell cycle arrest and apoptosis.

Mechanism of action and molecular targets

The pharmacological activity of root alkaloids originates from their interactions with various biomolecules. Its mechanism of action exhibits typical multi-target and multi pathway characteristics, which is not only a reflection of the complexity of natural products, but also the source of its unique therapeutic advantages.

1. Acetylcholinesterase inhibition mechanism

The inhibition of acetylcholinesterase (AChE) by matrine is one of its most clear molecular targets. Molecular docking and dynamic simulation studies have shown that the quaternary ammonium cation head of jatrorrhizine can undergo π - cation interactions with tryptophan (Trp86) residues in the anionic sub site of the AChE active site center. Meanwhile, its isoquinoline ring skeleton can form π - π stacking interactions with aromatic amino acid residues (such as Phe330, Tyr337) in the active site canyon. In addition, the hydroxyl group at C-3 position and the methoxy groups at C-9 and C-10 positions may interact with residues in catalytic trimesters (Ser203, His447, Glu334) or oxygen anion holes through hydrogen bonding, thereby stabilizing enzyme inhibitor complexes and hindering the binding of acetylcholine to active sites. Its high selectivity towards BuChE may be attributed to the differences in the canyon structure of the two enzyme active sites, particularly the larger acyl binding pocket in BuChE, which may not form optimal interactions with specific substituents of jatrorrhizine.

2. Inhibition mechanism of reuptake of monoamine neurotransmitters

Yaogen alkaloids reduce the reuptake of 5-HT and NE by inhibiting the uptake-2 transporter. Uptake-2 is a low affinity, high-capacity transport system primarily mediated by organic cation transporters (OCTs, particularly OCT2 and OCT3). Unlike classic antidepressants such as SSRIs and SNRIs, which target high affinity uptake-1 transporters (SERT and NET), the target of action of matrine is OCTs. Research has shown that matrine can directly bind to OCT2 or OCT3, competitively inhibiting their transport of monoamine neurotransmitters. This mechanism provides new ideas for the development of novel antidepressant drugs, especially for patients who do not respond well to traditional SSRIs/SNRIs. Regulating uptake-2 may be an effective complementary or alternative strategy.

3. Multi target mechanism of antibacterial activity

The antibacterial effect of matrine is not achieved through a single target, but through simultaneous action on multiple key targets.
- Inhibit DNA replication Medicinal root alkaloids can embed into bacterial DNA double helix, interfere with DNA topology, and inhibit the activity of DNA gyrase (GyrA/GyrB), thereby blocking DNA replication and transcription.
- Inhibit cell division Medicinal root alkaloids can bind to the key protein FtsZ in bacterial cell division, interfering with its polymerization to form a Z-ring, thereby inhibiting the process of cell division.
- Inhibit fatty acid synthesis Medicinal root alkaloids can inhibit the key enzyme in bacterial fatty acid synthesis pathway, acetyl ACP reductase (FabI), and block the synthesis of cell membrane phospholipids.
- folic acid metabolism Medicinal root alkaloids can inhibit dihydrofolate reductase (DHFR) and interfere with bacterial nucleotide and amino acid synthesis.
- Antifungal mechanism In fungi, jatrorrhizine mainly inhibits the 14 α - demethylase (ERG11/CYP51) in the ergosterol synthesis pathway, leading to the disruption of cell membrane structure. At the same time, it can also inhibit multidrug resistance transporters (such as CDR1), increase the accumulation of drugs in fungal cells, and thus reverse drug resistance.

4. Antioxidant and anti-inflammatory mechanisms

The antioxidant activity of medicinal root alkaloids originates from their direct free radical scavenging ability at the phenolic hydroxyl group (C-3 position). In addition, it can also upregulate the expression of a series of antioxidant enzymes (such as HO-1 and NQO1) by activating the nuclear factor E2 related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway, enhancing the endogenous antioxidant defense ability of cells. In terms of anti-inflammatory effects, matrine can inhibit the activation of nuclear factor kappa B (NF - κ B) and mitogen activated protein kinase (MAPK) signaling pathways, thereby reducing the production of pro-inflammatory cytokines and mediators.

Evaluation of drug properties and pharmacokinetics

To promote the clinical application of matrine from laboratory research, it is necessary to rigorously evaluate its druglikelihood and pharmacokinetic (ADME) properties. Based on the provided pharmacological parameters, we can analyze the potential and challenges of berberine.

Analysis of pharmacological parameters:
- Molecular weight (338.38 Da)Meeting the requirement of molecular weight<500 in the Lipinski Five Rules is beneficial for the development of oral drugs.
- LogP (0.5732)Within the ideal range (0-3), it indicates that it has both hydrophilicity and lipophilicity, which is beneficial for dissolution and transmembrane transport.
- TPSA (51.80 Ų)Slightly higher than the ideal range for oral medication (usually<40 Å ²), but still within an acceptable range. The higher TPSA is mainly derived from quaternary ammonium ions and polar substituents, which may lead to poor cell membrane permeability, especially difficulty in penetrating the blood-brain barrier (BBB).
- Water solubility (0.4907): Belongs to a moderate to low level. Although the quaternary ammonium salt structure endows it with certain water solubility, its overall water solubility is still not ideal, which may affect its oral absorption and bioavailability.
- Blood-brain barrier (BBB) penetration (low)This is the biggest challenge faced by the development of matrine as a central nervous system (CNS) drug. Its quaternary ammonium salt structure and high polarity make it difficult to cross the BBB through passive diffusion. However, this is not an absolute barrier, as some quaternary ammonium alkaloids (such as berberine) have been shown to enter the brain through carrier mediated transport (such as OCTs) or temporary opening of the BBB. In addition, low BBB penetration may also indicate fewer peripheral side effects.
- HERG inhibition (No)This is a very positive signal. HERG potassium channel inhibition is the main cause of drug-induced cardiac toxicity (QT interval prolongation). Medicinal root alkaloids do not inhibit hERG, indicating a lower risk of cardiac toxicity.
- Ames test (0.9)Ames test is used to evaluate the mutagenicity of compounds. A value of 0.9 indicates that jatrorrhizine is negative or weakly positive in the Ames test, suggesting a low risk of genetic toxicity.

Pharmacokinetic characteristics:
There is relatively limited research on the pharmacokinetics of matrine, but some preliminary findings have been made:
- absorb After oral administration, the absorption of matrine in the gastrointestinal tract may be poor, which is related to its quaternary ammonium salt structure and lower water solubility. Its absolute bioavailability may be low. However, some studies suggest that matrine may be partially absorbed through transporters in the intestine, such as OCTs.
- distribution After intravenous injection, matrine is widely distributed in the body, but its concentration in brain tissue is usually low, consistent with its prediction of low BBB penetration. It may have a high distribution in tissues such as the liver, kidneys, and lungs.
- Metabolism Medicinal root alkaloids are mainly metabolized in the liver. The main metabolic pathways include demethylation, glucuronidation, and sulfation. Its metabolites may retain some biological activity.
- excretion Medicinal root alkaloids and their metabolites are mainly excreted through bile and urine. Due to the quaternary ammonium salt structure, its renal tubular reabsorption may be less, which is beneficial for its clearance from the body.

Summary of drug properties:
Medicinal root alkaloids have some good medicinal properties, such as moderate molecular weight, reasonable LogP, no hERG inhibition, and low genetic toxicity risk. However, its biggest challenge lies in Low water solubility and Low BBB penetration For the development of drugs with peripheral effects such as antibacterial and anti-inflammatory, low BBB penetration may be an advantage. But for the development of CNS drugs (such as anti AD, anti depression), this obstacle must be overcome through drug chemistry or novel drug delivery systems. Future research should focus on:
1. Prodrug design Modify the hydroxyl or quaternary ammonium groups of root alkaloids to make prodrugs, in order to improve their lipid solubility and BBB penetration, and then convert them into active forms in vivo.
2. Nano drug delivery system Using carriers such as liposomes, polymer nanoparticles, and solid lipid nanoparticles to encapsulate drug alkaloids, improving their water solubility, stability, and targeting, especially for brain targeted delivery.
3. Structural modification On the basis of maintaining the core pharmacophore, systematically modify the substituents of alkaloids to search for derivatives with higher activity and better pharmacokinetic properties.

Clinical application prospects and prospects

Based on its unique pharmacological activity and multi-target mechanism of action, matrine has shown broad clinical application prospects in multiple disease fields, but also faces clear challenges.

1. Neurodegenerative diseases (Alzheimer's disease)

This is the most promising application direction of root alkaloids. Its multiple effects of selective AChE inhibition, antioxidant, anti A β toxicity, and anti neuroinflammation make it an ideal candidate molecule for the treatment of AD. However, low BBB penetration is its main bottleneck. Future research should focus on:
- Develop brain targeted drug delivery system Using nanoparticles modified with transferrin receptors or glucose transporters to achieve efficient delivery of alkaloids in the brain.
- Design new derivatives By structural modification, such as converting quaternary ammonium groups into tertiary amines or introducing more lipophilic groups, the ability to passively diffuse and penetrate the BBB can be improved.
- combination therapy Combining with existing AD treatment drugs such as donepezil and memantine may result in synergistic effects and reduce the dosage and side effects of individual drugs.

2. infectious diseases (especially drug-resistant bacteria infection)

Faced with the increasingly severe crisis of antibiotic resistance, the multi-target antibacterial mechanism of matrine makes it a valuable lead compound for the development of new antibacterial drugs. Its application prospects include:
- Developing anti MRSA drugs Medicinal root alkaloids have good activity against MRSA and are not easily resistant, making them a promising new option for treating MRSA infections.
- Antifungal sensitizer By inhibiting fungal efflux pump 1 (CDR1), berberine can reverse the resistance of Candida albicans to azole drugs such as fluconazole, and its combination with existing antifungal drugs can improve efficacy.
- Anti Helicobacter pylori Yaogen alkaloid has an inhibitory effect on Helicobacter pylori and is expected to be used as an adjuvant therapy for the treatment of gastric ulcers and gastric cancer.

3. Mental disorders (depression)

The mechanism by which matrine increases 5-HT and NE levels by inhibiting the uptake-2 transporter provides a new target for the treatment of depression. Compared with traditional SSRIs/SNRIs, their mechanism of action is different and may be effective for patients with refractory depression. In addition, its low BBB penetration may indicate fewer central side effects (such as anxiety and insomnia), but at the same time, it also needs to address how to effectively enter the brain.

4. Other fields

• cardiovascular disease Its vasodilation, antiplatelet aggregation, and anti myocardial ischemia effects make it potential for cardiovascular protection.
• Metabolic diseases Some preliminary studies suggest that matrine may have a regulatory effect on blood glucose and blood lipids, but its mechanism and efficacy still need further investigation.
• antitumor As an adjuvant therapy drug, matrine may exert its effect by enhancing the sensitivity of chemotherapy drugs or reducing their toxic side effects.

Outlook:
Medicinal root alkaloids, as a natural product with a long history, are being re evaluated for their modern pharmacological value. Future research should delve into the following directions:
1. Deepening mechanism research Using systems biology and network pharmacology methods, comprehensively reveal the "multi-target multi pathway" action network of matrine, and elucidate the molecular basis of its complex pharmacological effects.
2. Optimization of Medicinal Chemistry A systematic structure-activity relationship (SAR) study was conducted using berberine as the lead, and a series of derivatives with higher activity, better selectivity, and better pharmacokinetic properties were designed and synthesized.
3. Innovation in formulation technology Develop new drug delivery systems, especially brain targeted delivery systems for CNS diseases, to overcome the BBB penetration barrier of alkaloids.
4. Advancement of preclinical and clinical research After completing the pharmacological, pharmacokinetic, and toxicological evaluations of the system, actively promote the clinical trial phase of alkaloids or their derivatives to verify their safety and efficacy in humans.

Conclusion

Yaogen alkaloid, an isoquinoline alkaloid derived from traditional Chinese medicine such as Huanglian, is moving from the depths of history to the forefront of modern drug development. Based on its unique chemical structure, it exhibits astonishing versatility: it is both a selective acetylcholinesterase inhibitor and a multi-target antibacterial molecule, as well as regulating monoamine neurotransmitters. The characteristic of "one drug, multiple targets" enables it to demonstrate unique advantages that traditional single target drugs do not possess when dealing with complex diseases such as Alzheimer's disease, drug-resistant bacterial infections, and depression.

However, the road to becoming a medicinal herb with alkaloids is not smooth. The low water solubility and blood-brain barrier penetration caused by its quaternary ammonium salt structure are the main bottlenecks restricting its clinical translation. But this is not an insurmountable obstacle. Through modern pharmaceutical chemistry and formulation techniques such as prodrug design, nano delivery systems, and structural optimization, we have every reason to believe that these challenges can be gradually overcome.

The research process of medicinal alkaloids is a microcosm of the discovery of natural product drugs. It reminds us that while pursuing highly active and selective "magic bullet" drugs, we should not ignore those seemingly "imperfect" natural molecules. Their complex mechanisms of action and unique physicochemical properties precisely contain the key to solving complex disease problems. The in-depth exploration of medicinal alkaloids is not only expected to bring new therapeutic drugs to humanity, but also deepen our understanding of the chemical and biological nature of natural products, providing valuable insights for future drug discovery. With the continuous deepening of research and the advancement of technological means, the precious gem of traditional Chinese medicine, Yaogen alkaloid, will surely shine even brighter on the stage of modern medicine.